| Class |
Group |
Description |
|
278
|
300
|
Injection, 9mcg; 0.3ml Single-Dose
|
|
278
|
300
|
Injection, 9mcg; 0.3ml Single-Dose
|
|
278
|
300
|
Injection, 15mcg; 0.5ml Single-Dose
|
|
278
|
300
|
Injection, 15mcg; 0.5ml Single-Dose
|
|
278
|
300
|
Interferon Alfa-2b, Recombinate,
|
|
278
|
300
|
Injection, Capsule; 3mun/0.5ml Vails
|
|
278
|
300
|
Injection, Capsule; 6 3un/0.5ml Vails
|
|
278
|
300
|
Injection, Capsule; 18mun (3mun/0.5ml)
|
|
278
|
300
|
Injection, Capsule; 6mun/0.5ml Vails
|
|
278
|
300
|
Gemcitabine, Usp
|
|
278
|
300
|
Powder For Injection; 20mcg/Ml;
|
|
278
|
300
|
Dacarbazne, Usp
|
|
278
|
300
|
Powder For Injection, 200mg/Vial
|
|
278
|
550
|
Hormones, Antineoplastic Drugs
|
|
278
|
550
|
Leuprolide Acetate
|
|
278
|
550
|
Injection, Depot Suspension, 7.5 Mg/Ml
|
|
278
|
550
|
Megestrol Acetate, Usp
|
|
278
|
550
|
Tablet; 40mg; 100/Btl.
|
|
278
|
550
|
Tablet; 40mg; Ud 100/Box.
|
|
278
|
550
|
Tablet; 40mg; 500/Btl.
|
|
278
|
550
|
Tamoxifen Citrate
|
|
278
|
550
|
Tablet, 10 Mg, 60/Bottle.
|
|
278
|
550
|
Tablet, 10 Mg, 250/Bottle.
|
|
278
|
720
|
Mitotic Inhibitors, Antineoplastic Drugs
|
|
278
|
720
|
Etoposide
|
|
278
|
720
|
Injection; 20mg/Ml; 5ml Vial
|
|
278
|
720
|
Capsule, W/Cytoguard, 50 Mg, Ud, 20/Pkg.
|
|
278
|
720
|
Vincristine Sulfate, Usp
|
|
278
|
720
|
Injection; 1mg/Ml; 1ml Vial.
|
|
278
|
720
|
Injection; 1mg/Ml; 1ml Syringe 3/Pkg.
|
|
278
|
720
|
Vincristine Sulfate, Injection, 1mg/Ml,
|
|
278
|
800
|
Radiopharmaceuticals, Antineoplastic
|
|
278
|
990
|
National Cancer Institute Investiga-
|
